14-day Premium Trial Subscription Try For FreeTry Free

Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of BLUE
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Thursday for bluebird bio
(Updated on Apr 25, 2024)

Sell candidate since Apr 12, 2024 Loss -17.05% PDF

The bluebird bio stock price fell by -1.13% on the last day (Thursday, 25th Apr 2024) from $0.92 to $0.91. During the last trading day the stock fluctuated 5.53% from a day low at $0.88 to a day high of $0.93. The price has fallen in 8 of the last 10 days and is down by -21.34% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -2 million shares and in total, 6 million shares were bought and sold for approximately $5.17 million.

The stock is at the lower part of a very wide and horizontal trend in the short term, and normally this may pose a good buying opportunity, though a breakdown through the bottom trend line at $0.91 will give a strong sell signal and a trend shift may be expected. Given the current horizontal trend, you can expect bluebird bio stock with a 90% probability to be traded between $0.91 and $1.76 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

BLUE Signals & Forecast

There are few to no technical positive signals at the moment. The bluebird bio stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.96 and $1.22. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, February 27, 2024, and so far it has fallen -47.86%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for bluebird bio stock

bluebird bio finds support from accumulated volume at $0.91 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.0487 between high and low, or 5.53%. For the last week, the stock has had daily average volatility of 9.42%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (BLUE) For The Upcoming Trading Day Of Friday 26th

For the upcoming trading day on Friday, 26th we expect bluebird bio to open at $0.91, and during the day (based on 14 day Average True Range), to move between $0.81 and $1.02, which gives a possible trading interval of +/-$0.107 (+/-11.68%) up or down from last closing price. If bluebird bio takes out the full calculated possible swing range there will be an estimated 23.36% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.91 (0.80%) than the resistance at $1.02 (11.78%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is bluebird bio stock A Buy?

bluebird bio holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -4.967 Sell Candidate Unchanged

Predicted Opening Price for bluebird bio of Friday, April 26, 2024

Fair opening price April 26, 2024 Current price
$0.91 ( 0.500%) $0.91

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for BLUE

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.96 4.84 %
R2 0.94 2.80 %
R1 0.93 1.54 %
Current price: 0.91
Support S1 0.89 -2.54 %
S2 0.88 -3.80 %
S3 0.86 -5.84 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 1.10 20.55 %
R2 1.06 16.16 %
R1 1.02 11.78 %
Current price 0.91
Support S1 0.91 -0.80%
S2 0 .
S3 0 .

FAQ

What is the symbol for bluebird bio Stock and on which exchange is it traded?
The symbol for bluebird bio is BLUE and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell bluebird bio Stock?
bluebird bio holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy bluebird bio Stock?
bluebird bio Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy bluebird bio Stock.

What's the current price of bluebird bio Stock?
As of the end of day on the Apr 25, 2024, the price of an bluebird bio (BLUE) share was $0.91.

What is the 52-week high and low for bluebird bio Stock?
The 52-week high for bluebird bio Stock is $5.53 and the 52-week low is $0.88.

What is the market capitalization of bluebird bio Stock?
As of the Apr 25, 2024, the market capitalization of bluebird bio is 175.877M.

When is the next earnings date for bluebird bio?
The upcoming earnings date for bluebird bio is May 14, 2024.
Click to get the best stock tips daily for free!

About bluebird bio

bluebird bio bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell disease (SCD); and elivaldogene autotemcel to treat cerebral adrenoleukodystrophy. The company's clini... BLUE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT